A detailed history of Man Group PLC transactions in Axonics, Inc. stock. As of the latest transaction made, Man Group PLC holds 648,847 shares of AXNX stock, worth $46.1 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
648,847
Previous 956,801 32.19%
Holding current value
$46.1 Million
Previous $64.3 Million 29.72%
% of portfolio
0.13%
Previous 0.17%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.3 - $69.67 $20.7 Million - $21.5 Million
-307,954 Reduced 32.19%
648,847 $45.2 Million
Q2 2024

Aug 14, 2024

BUY
$66.47 - $69.65 $11.1 Million - $11.6 Million
166,374 Added 21.05%
956,801 $64.3 Million
Q1 2024

May 15, 2024

BUY
$56.67 - $69.36 $44.8 Million - $54.8 Million
790,427 New
790,427 $54.5 Million
Q2 2023

Aug 14, 2023

SELL
$47.99 - $60.21 $2.68 Million - $3.36 Million
-55,812 Reduced 15.22%
310,803 $15.7 Million
Q1 2023

May 15, 2023

BUY
$52.6 - $67.34 $5.43 Million - $6.95 Million
103,137 Added 39.14%
366,615 $20 Million
Q4 2022

Feb 14, 2023

BUY
$59.56 - $76.6 $3.24 Million - $4.16 Million
54,346 Added 25.99%
263,478 $16.5 Million
Q3 2022

Nov 14, 2022

BUY
$57.96 - $78.12 $9.66 Million - $13 Million
166,723 Added 393.13%
209,132 $14.7 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $1.52 Million - $2.48 Million
38,549 Added 998.68%
42,409 $2.4 Million
Q1 2022

May 16, 2022

BUY
$43.74 - $62.76 $168,836 - $242,253
3,860 New
3,860 $242,000
Q1 2021

May 17, 2021

SELL
$49.14 - $59.89 $199,655 - $243,333
-4,063 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$42.19 - $51.5 $791,273 - $965,882
-18,755 Reduced 82.19%
4,063 $203,000
Q3 2020

Nov 16, 2020

SELL
$35.33 - $51.04 $335,175 - $484,216
-9,487 Reduced 29.37%
22,818 $1.17 Million
Q2 2020

Aug 14, 2020

BUY
$22.91 - $39.83 $740,107 - $1.29 Million
32,305 New
32,305 $1.13 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.